141. Work participation in patients with systematic lupus erythematosus: a systematic review.
作者: Birgit S Blomjous.;Gayle R S Gajadin.;Alexandre E Voskuyl.;Louise Falzon.;Jan L Hoving.;Irene E M Bultink.;Marieke M Ter Wee.
来源: Rheumatology (Oxford). 2022年61卷7期2740-2754页
This systematic review assessed which variables are associated with or are predictors for work participation outcomes in patients with systematic lupus erythematosus (SLE).
142. Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study.
作者: Michael Hughes.;Elisabetta Zanatta.;Robert D Sandler.;Jérôme Avouac.;Yannick Allanore.
来源: Rheumatology (Oxford). 2022年61卷7期2755-2769页
Vascular disease in SSc is associated with significant morbidity and mortality. Preliminary data may lead to the suggestion of a modifiable unified-vascular endophenotype. Our aim was to determine whether the prevalence, mortality and severity of SSc-vascular disease have changed over time.
143. Racial disparities in skin tone representation of dermatomyositis rashes: a systematic review.
作者: Sofia Babool.;Salman F Bhai.;Collin Sanderson.;Amber Salter.;Lisa Christopher-Stine.
来源: Rheumatology (Oxford). 2022年61卷6期2255-2261页
This systemic review assesses skin tone representation in images of DM rashes in medical education literature.
144. Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.
作者: Alexander G S Oldroyd.;Andrew B Allard.;Jeffrey P Callen.;Hector Chinoy.;Lorinda Chung.;David Fiorentino.;Michael D George.;Patrick Gordon.;Kate Kolstad.;Drew J B Kurtzman.;Pedro M Machado.;Neil J McHugh.;Anna Postolova.;Albert Selva-O'Callaghan.;Jens Schmidt.;Sarah Tansley.;Ruth Ann Vleugels.;Victoria P Werth.;Rohit Aggarwal.
来源: Rheumatology (Oxford). 2021年60卷11期5483页 145. Targeting neurotrophic factors for low back pain and sciatica: a systematic review and meta-analysis.
作者: Rodrigo R N Rizzo.;Michael C Ferraro.;Michael A Wewege.;Aidan G Cashin.;Hayley B Leake.;Edel T O'Hagan.;Matthew D Jones.;Sylvia M Gustin.;Andrew J McLachlan.;Richard Day.;James H McAuley.
来源: Rheumatology (Oxford). 2022年61卷6期2243-2254页
This meta-analysis aims to investigate the efficacy and safety of medicines that target neurotrophic factors for low back pain (LBP) or sciatica.
146. Assessing the role for nailfold videocapillaroscopy in interstitial lung disease classfication: a systematic review and meta-analysis.
作者: Eshwar Umashankar.;Christina Abdel-Shaheed.;Marshall Plit.;Laila Girgis.
来源: Rheumatology (Oxford). 2022年61卷6期2221-2234页
The nailfold videocapillaroscopy (NVC) has been known to assist with interstitial lung disease (ILD) classification. However, evidence on its diagnostic efficacy is limited, particularly in some connective tissue disease-related interstitial lung diseases (CTD-ILD), and in interstitial pneumonia with autoimmune features (IPAF). This study aimed to address this limitation by conducting a meta-analysis on the efficacy of the NVC in ILD subgroups of CTD-ILD, IPAF and idiopathic pulmonary fibrosis (IPF).
147. Placebo response in psoriatic arthritis clinical trials: a systematic review and meta-analysis.
作者: Gian Luca Erre.;Dimitris Mavridis.;Richard John Woodman.;Arduino Aleksander Mangoni.
来源: Rheumatology (Oxford). 2022年61卷4期1328-1340页
To determine the placebo response rate in PsA randomized clinical trials (RCTs), its contributing factors and impact on the effect size of active treatments.
148. Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and meta-analysis of clinical trial studies.
The present systematic review and meta-analysis was conducted to assess the effect of tocilizumab (TCZ) in patients with rheumatoid arthritis (RA). We systematically searched all potential articles in the main databases, including PubMed, Scopus, EMBASE, Web of Sciences (ISI), and Cochrane Center. The search was subsequently updated in December 2020. The initial review and extraction of information were performed independently by two authors to collect the first author and publication year; sample size; mean age of the intervention and control groups; the dose of TCZ, and the follow-up duration. Outcomes of interest include the ACR20, ACR50, ACR70, total complication rate, and the occurrence of remission. Any disagreements between the reviewers were resolved by discussion and re-check of the article and consultation with a third reviewer. After reviewing and culling, 15 clinical trials comparing the clinical efficacy of TCZ and its comparators in the treatment of patients with RA entered the qualitative and quantitative synthesis. Tocilizumab 8 mg was statistically better than 4 mg or placebo for ACR responses. Significant clinical adverse events in patients with RA treated with TCZ, such as abnormal liver function tests (LFTs) and infections, were more frequent than in comparator groups. This systematic review and meta-analysis suggest that the combination therapy of TCZ with other drugs such as methotrexate and disease-modifying antirheumatic drugs has been studied for various clinical effects concerning safety and clinically significant adverse events. Although the data are promising, long-term performance and safety data need to be fully identified, as well as the risks and benefits of TCZ, especially appropriate timing, dosage, and regimen.
149. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis.
作者: Evdoxia Kyriazopoulou.;Thomas Huet.;Giulio Cavalli.;Andrea Gori.;Miltiades Kyprianou.;Peter Pickkers.;Jesper Eugen-Olsen.;Mario Clerici.;Francisco Veas.;Gilles Chatellier.;Gilles Kaplanski.;Mihai G Netea.;Emanuele Pontali.;Marco Gattorno.;Raphael Cauchois.;Emma Kooistra.;Matthijs Kox.;Alessandra Bandera.;Hélène Beaussier.;Davide Mangioni.;Lorenzo Dagna.;Jos W M van der Meer.;Evangelos J Giamarellos-Bourboulis.;Gilles Hayem.; .
来源: Lancet Rheumatol. 2021年3卷10期e690-e697页
Anakinra might improve the prognosis of patients with moderate to severe COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). We aimed to assess the effect of anakinra treatment on mortality in patients admitted to hospital with COVID-19.
150. The response to TNF blockers depending on their comparator in rheumatoid arthritis clinical trials: the lessebo effect, a meta-analysis.
作者: Lea Lopez.;Romain Griffier.;Thomas Barnetche.;Edouard Lhomme.;Marie Kostine.;Marie-Elise Truchetet.;Thierry Schaeverbeke.;Christophe Richez.
来源: Rheumatology (Oxford). 2022年61卷2期531-541页
To compare the effect of the biological reference agents (infliximab, etanercept, adalimumab) in RA in pivotal superiority placebo-controlled trials (reference agent vs placebo) vs their effect in equivalence active comparator-controlled trials (reference agent vs biosimilar).
151. Moving from nature to nurture: a systematic review and meta-analysis of environmental factors associated with juvenile idiopathic arthritis.
作者: Sarah L N Clarke.;Katie S Mageean.;Ilaria Maccora.;Sean Harrison.;Gabriele Simonini.;Gemma C Sharp.;Caroline L Relton.;Athimalaipet V Ramanan.
来源: Rheumatology (Oxford). 2022年61卷2期514-530页
JIA is the most common paediatric rheumatic disease, thought to be influenced by both genetics and the environment. Identifying environmental factors associated with disease risk will improve knowledge of disease mechanism and ultimately benefit patients. This review aimed to collate and synthesize the current evidence of environmental factors associated with JIA.
152. Fertility and pregnancy outcomes in women with spondyloarthritis: a systematic review and meta-analysis.
作者: Sabrina Hamroun.;Aghilès Hamroun.;Jean-Joël Bigna.;Edem Allado.;Frauke Förger.;Anna Molto.
来源: Rheumatology (Oxford). 2022年61卷4期1314-1327页
The aim of this study was to determine the impact of SpA and its treatments on fertility and pregnancy outcomes, as well as the impact of pregnancy on disease activity.
153. Treatment strategies for Sjögren's syndrome with childhood onset: a systematic review of the literature.
作者: Georgia Doolan.;Nor Mohd Faizal.;Charlene Foley.;Muthana Al-Obaidi.;Elizabeth C Jury.;Elizabeth Price.;Athimalaipet V Ramanan.;Scott M Lieberman.;Coziana Ciurtin.
来源: Rheumatology (Oxford). 2022年61卷3期892-912页
SS with childhood onset is a rare autoimmune disease characterized by heterogeneous presentation. The lack of validated classification criteria makes it challenging to diagnose. Evidence-based guidelines for treatment of juvenile SS are not available due to the rarity of disease and the paucity of research in this patient population. This systematic review aims to summarize and appraise the current literature focused on pharmacological strategies for management of SS with childhood onset.
154. Defining cardiac involvement in idiopathic inflammatory myopathies: a systematic review.
作者: Jessica L Fairley.;Ian Wicks.;Stacey Peters.;Jessica Day.
来源: Rheumatology (Oxford). 2021年61卷1期103-120页
Recent advances in cardiac MRI (CMR) and other diagnostic techniques have made it easier to identify subclinical cardiac inflammation and dysfunction in the idiopathic inflammatory myopathies (IIM). Herein, we systematically review the literature regarding cardiac involvement in IIM.
155. Improving outcomes for patients hospitalized with gout: a systematic review.
作者: Mark D Russell.;Benjamin D Clarke.;Edward Roddy.;James B Galloway.
来源: Rheumatology (Oxford). 2021年61卷1期90-102页
Hospital admissions for gout flares have increased dramatically in recent years, despite widely available, effective medications for the treatment and prevention of flares. We conducted a systematic review to evaluate the effectiveness and implementation of interventions in patients hospitalized for gout flares.
156. The efficacy of systemic glucocorticosteroids for pain in rheumatoid arthritis: a systematic literature review and meta-analysis.
作者: Daniel F McWilliams.;Divya Thankaraj.;Julie Jones-Diette.;Rheinallt Morgan.;Onosi S Ifesemen.;Nicholas G Shenker.;David A Walsh.
来源: Rheumatology (Oxford). 2021年61卷1期76-89页
Glucocorticosteroids (GCs) are recommended to suppress inflammation in people with active RA. This systematic review and meta-analysis aimed to quantify the effects of systemic GCs on RA pain.
157. Correlation between pain severity and levels of anxiety and depression in osteoarthritis patients: a systematic review and meta-analysis.
作者: Diana Fonseca-Rodrigues.;André Rodrigues.;Teresa Martins.;Joana Pinto.;Diana Amorim.;Armando Almeida.;Filipa Pinto-Ribeiro.
来源: Rheumatology (Oxford). 2021年61卷1期53-75页
Osteoarthritis (OA) is a chronic degenerative musculoskeletal disease that causes articular damage and chronic pain, with a prevalence of up to 50% in individuals >60 years of age. Patients suffering from chronic painful conditions, including OA, also frequently report anxiety or depression. A systematic review and meta-analysis were performed to assess the correlation between pain severity and depressive and anxious symptomatology in OA patients.
158. Reliability of detection of ultrasound and MRI features of hand osteoarthritis: a systematic review and meta-analysis.
作者: Abasiama D Obotiba.;Subhashisa Swain.;Jaspreet Kaur.;Michael Doherty.;Weiya Zhang.;Abhishek Abhishek.
来源: Rheumatology (Oxford). 2022年61卷2期542-553页
To systematically review the literature on inter- and intra-rater reliability of scoring US and MRI changes in hand OA.
159. Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United Kingdom.
作者: Peter C Taylor.;Matthew Woods.;Catherine Rycroft.;Priya Patel.;Sophee Blanthorn-Hazell.;Toby Kent.;Marwan Bukhari.
来源: Rheumatology (Oxford). 2021年60卷11期4972-4981页
The burden and treatment landscape of RA is poorly understood. This research aimed to identify evidence on quality of life, caregiver burden, economic burden, treatment patterns and clinical outcomes for patients with moderate RA in the United Kingdom.
160. High frequency ultrasonography: reliable tool to measure skin fibrosis in SSC? A systematic literature review and additional pilot study.
作者: Amber Vanhaecke.;Maurizio Cutolo.;Lise Heeman.;Veronica Vilela.;Ellen Deschepper.;Karin Melsens.;Vanessa Smith.
来源: Rheumatology (Oxford). 2021年61卷1期42-52页
To investigate the reliability of high frequency ultrasound (HFUS) in measuring skin fibrosis in SSc.
|